From a notice I got re update. Stated phase 1/2
so not just safety, efficiacy also.
"The clinical study is anticipated to be sponsored by the South Metropolitan Health Service, Department of Health, Government of Western Australia. The Fiona Stanley Hospital has been nominated as the study site and a separate trial agreement will be finalised in due course.
The Phase I/II topical study will assess RECCE 327 as a broad-spectrum antibiotic for patients with Gram-positive and Gram-negative bacterial burn wound infectionsI"
Ann: HREC Approval to Start Phase I/II Burns Wound Study, page-26
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.0¢ | 30.0¢ | $25.76K | 82.29K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13550 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 18938 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |